Fluorescent bioprobes for visualization of puromycin-sensitive aminopeptidase in living cells

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 1, 2003, Pages 83-86

  Kakuta, Hiroki ^a   Koiso, Yukiko ^a   Nagasawa, Kazuo ^a   Hashimoto, Yuichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1N METHYL 3 (2,6 DIETHYLPHENYL) 2,4(1H,3H) QUINAZOLINEDIONE; 3 (2,6 DIETHYLPHENYL) 2,4(1H,3H) QUINAZOLINEDIONE; AMINOPEPTIDASE; FLUORESCENT DYE; MPAQ 22; PAQ 22; PUROMYCIN SENSITIVE AMINOPEPTIDASE; THALIDOMIDE DERIVATIVE; UNCLASSIFIED DRUG; PUROMYCIN; QUINAZOLINE DERIVATIVE;

ARTICLE; CELL LINE; CHEMICAL MODIFICATION; DRUG STRUCTURE; ENZYME ASSAY; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MONOCYTE; STRUCTURE ACTIVITY RELATION; CELL CULTURE; CHEMISTRY; DRUG ANTAGONISM; FLUORESCENCE MICROSCOPY; IC 50; KINETICS; SYNTHESIS; VALIDATION STUDY;

AMINOPEPTIDASES; FLUORESCENT DYES; HUMANS; INHIBITORY CONCENTRATION 50; KINETICS; MICROSCOPY, FLUORESCENCE; PUROMYCIN; QUINAZOLINES; TUMOR CELLS, CULTURED;

EID: 0037421050     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(02)00845-4     Document Type: Article

References (22)

1. Hersh L.B., McKelvy J.F. J. Neurochem. 36:1981;171.
2. McLellan S., Dyer S.H., Hersh L.B. J. Neurochem. 51:1988;1552.
3. Johnson G.D., Hersh L.B. Arch. Biochem. Biophys. 276:1990;305.
4. Rawlings N.D., Barrett A.J. Biochem. J. 290:1993;201.
5. Tobler A.R., Constam D.B., Schmitt-Graff A., Malipiero U., Schlabach R., Fontana A. J. Neurochem. 68:1997;889.
6. Costam D.B., Tobler A.R., Rensing-Ehl A., Kelmer I., Hersh L.B., Fontana A. J. Biol. Chem. 270:1995;26931.
7. Bauer M.O., Nanda I., Beck G., Schmid M., Jacob F. Cytogenet. Cell Genet. 92:2001;221.
8. Osada T., Ikegami S., Takiguchi-Hayashi K., Yamazaki Y., Katoh-Fukui Y., Higashikanagawa T., Sasaki Y., Takeuchi T. J. Neurochem. 19:1999;6068.
9. Hashimoto Y. Bioorg. Med. Chem. 10:2002;461.
10. Hashimoto Y. Curr. Med. Chem. 5:1998;163.
11. Shimazawa R., Takayama H., Fujimoto Y., Komoda M., Dodo K., Yamasaki Y., Shirai R., Koiso Y., Miyata K., Kato F., Kato M., Miyachi, Hashimoto Y. J. Enzyme Inhibit. 14:1999;259.
12. Takahashi H., Komoda M., Kakuta H., Hashimoto Y. Yakugaku Zasshi. 120:2000;909.
13. Kakuta H., Takahashi H., Sou S., Kita T., Nagasawa K., Hashimoto Y. Recent Res. Develop. Med. Chem. 1:2001;189.
14. Miyachi H., Kato M., Kato F., Hashimoto Y. J. Med. Chem. 41:1998;263.
15. Kakuta H., Koiso Y., Takahashi H., Nagasawa K., Hashimoto Y. Heterocycles. 55:2001;1433.
16. Komoda M., Kakuta H., Takahashi H., Fujimoto Y., Kadoya S., Kato F., Hashimoto Y. Bioorg. Med. Chem. 9:2001;121.
17. Kagechika H., Komoda M., Fujimoto Y., Koiso Y., Takayama H., Kadoya S., Miyata K., Kato F., Kato M., Hashimoto Y. Biol. Pharm. Bull. 22:1999;1010.
18. 2), 360/405 nm (MeOH).
19. 2), 320/510 nm (MeOH).
20. Shimazawa R., Hibino S., Mizoguchi H., Hashimoto Y., Iwasaki S., Kagechika H., Shudo K. Biochem. Biophys. Res. Comm. 180:1991;249.
21. Hashimoto Y., Shimazawa R. Clin. Dermatol. 5:1993;585.
22. Sawada T., Kato Y., Kobayashi H., Hashimoto Y., Watanabe T., Sugiyama Y., Iwasaki S. Bioconjugate Chem. 4:1993;284.